Search

You searched for "Wales"

2866 results found

My Top Five: Ophthalmology Twitter accounts

3 October 2022 | | EYE - General
There are approximately 4.2 billion active social media users worldwide. This figure represents over half of the global population and is steadily rising [1]. There are currently over 217 million active Twitter users and given the platform’s versatility and ability...

Katie Piper and a host of stars mark World Sight Day 2025 with International Eye Care Charity Orbis

20 October 2025 | Orbis, charity, accessibility, WSD25, World Sight Day
To celebrate World Sight Day, Orbis, the international eyecare charity, hosted an intimate breakfast event this morning at the historic St Pancras London Hotel, situated in King’s Cross. The gathering brought together high-profile people from the worlds of entertainment, fashion,...

How the development of Glaucoma Guidelines, Glaucoma Toolkit and GLASS training and the Glaucoma nurse training can effect change in Nigeria

4 February 2025 | | EYE - Glaucoma
In July 2024, a combined training, led by Fatima Kyari, was run in Abuja, Nigeria to facilitate a multifaceted upskilling in glaucoma management. The first week comprised of inviting 36 doctors practising glaucoma from around Nigeria’s 36 states, including the...

Hidden eyelid laceration following blunt trauma

3 April 2024 | | EYE - Oculoplastic, EYE - Cornea, EYE - General
A paediatric case report of a hidden eyelid laceration following blunt trauma. Blunt injury to the eyelid can result in a multitude of issues, such as damage to the eyelid margin, lacrimal system and surrounding orbit [1]. These can often...

Presumed DALK stromal graft rejection following Covid-19 infection

4 December 2024 | | EYE - Cornea
Case report A 45-year-old healthy male patient with a past ocular history of keratoconus and right deep-anterior lamellar keratoplasty (DALK) graft performed 10 months prior, presented to our eye casualty clinic with a two-day history of right photophobia and epiphora....

Shedding light on Wolfram syndrome: The unveiling of a delayed diagnosis

12 August 2025 | | EYE - Neuro-ophthalmology
Wolfram syndrome 1 (WS1) was first described by Wolfram and Wagener in 1938 and it’s a rare neurodegenerative, progressive disorder, also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness) [1]. We present an atypical case of WS...

My top five: Innovative approaches to dry AMD

2 February 2024 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

In conversation with Yasmin El-Rouby

2 February 2024 | | EYE - General
Author and Eye Doctor, Dr Yasmin El-Rouby, wishes to raise awareness about common vision disorders. Envisioning a world where preventable eye conditions are caught early, she founded Baseera, a non-profit organisation, to improve access to basic eyecare in developing countries....

My Top Five: Innovative approaches to dry AMD

2 February 2024 | | EYE - General
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

My Top Five: Social movements changing eyecare awareness

2 April 2025 | | EYE - General
Throughout recent years, the rise of the digital age has allowed for social movements to receive far greater awareness than was ever deemed possible. As a result, significant attention has been drawn towards initiatives focusing on a range of health...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

The management of retinal vein occlusions: a summary

1 February 2015 | | EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...